Terms: = Lung cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Treatment
336 results:
1. Mean computed tomography value to predict spread through air spaces in clinical N0 lung adenocarcinoma.
Yamamoto M; Tamura M; Miyazaki R; Okada H; Wada N; Toi M; Murakami I
J Cardiothorac Surg; 2024 Apr; 19(1):260. PubMed ID: 38654352
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance of inflammation scores in malignant mesothelioma.
Mutlu E; Inanc M
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2340-2350. PubMed ID: 38567597
[TBL] [Abstract] [Full Text] [Related]
3. The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancer.
Wallace ND; Alexander M; Xie J; Ball D; Hegi-Johnson F; Plumridge N; Siva S; Shaw M; Harden S; John T; Solomon B; Officer A; MacManus M
Lung Cancer; 2024 Apr; 190():107531. PubMed ID: 38513538
[TBL] [Abstract] [Full Text] [Related]
4. Canonical DDR activation by EMT inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression.
Mir KB; Chakraborty S; Amin T; Kumar A; Rouf War A; Nalli Y; Kumar R; Dinesh Kumar L; Ali A; Goswami A
Biochem Pharmacol; 2024 May; 223():116126. PubMed ID: 38490521
[TBL] [Abstract] [Full Text] [Related]
5. The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study.
Cheng WC; Lin CC; Liao WC; Lin YC; Chen CH; Chen HJ; Tu CY; Hsia TC
BMC Cancer; 2024 Feb; 24(1):228. PubMed ID: 38373960
[TBL] [Abstract] [Full Text] [Related]
6. First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial.
Zhong H; Sun S; Chen J; Wang Z; Zhao Y; Zhang G; Chen G; Zhou M; Zhou J; Du Y; Wu L; Xu Z; Mei X; Zhang W; He J; Cui J; Zhang Z; Luo H; Liu W; Sun M; Wu J; Shen Y; Zhang S; Yang N; Wang M; Lu J; Li K; Yao W; Sun Q; Yue H; Wang L; Ye S; Li B; Zhuang X; Pan Y; Zhang M; Shu Y; He Z; Pan L; Ling Y; Liu S; Zhang Q; Jiao S; Han B
Lancet Respir Med; 2024 May; 12(5):355-365. PubMed ID: 38309287
[TBL] [Abstract] [Full Text] [Related]
7. Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC.
Yang J; Choi J; Choi WM; Kim KM; Lee HC; Shim JH
Liver Int; 2024 Apr; 44(4):907-919. PubMed ID: 38291863
[TBL] [Abstract] [Full Text] [Related]
8. Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a Surveillance, Epidemiology, and End Results (SEER) analysis.
McGuire V; Lichtensztajn DY; Tao L; Yang J; Clarke CA; Wu AH; Wilkens L; Glaser SL; Park SL; Cheng I
Cancer Causes Control; 2024 May; 35(5):799-815. PubMed ID: 38206498
[TBL] [Abstract] [Full Text] [Related]
9. Long-term trends of lung cancer incidence and survival in southeastern China, 2011-2020: a population-based study.
Zhou Y; Xiang Z; Lin W; Lin J; Wen Y; Wu L; Ma J; Chen C
BMC Pulm Med; 2024 Jan; 24(1):25. PubMed ID: 38200537
[TBL] [Abstract] [Full Text] [Related]
10. Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients.
Kim S; Lim JH; Kim CH; Roh J; You S; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Heo J
Sci Rep; 2024 Jan; 14(1):922. PubMed ID: 38195717
[TBL] [Abstract] [Full Text] [Related]
11. Endobronchial Lipoma: A Rare Cause of Bronchial Stenosis or Obstruction.
Chen J; Xin T; Pan L; Li Y; Qian W; Wei J; Yan Y; Wang Y; Jin F; Jiang H
Can Respir J; 2023; 2023():2799436. PubMed ID: 38170103
[TBL] [Abstract] [Full Text] [Related]
12. Interplay of oxidative stress, cellular communication and signaling pathways in cancer.
Iqbal MJ; Kabeer A; Abbas Z; Siddiqui HA; Calina D; Sharifi-Rad J; Cho WC
Cell Commun Signal; 2024 Jan; 22(1):7. PubMed ID: 38167159
[TBL] [Abstract] [Full Text] [Related]
13. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
14. Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysis.
Pham JP; Rodrigues A; Goldinger SM; Sim HW; Liu J
Exp Dermatol; 2024 Jan; 33(1):e14978. PubMed ID: 37971204
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non-small cell lung cancer: A randomized, double-blind, phase III study.
Chen L; Rangel JDG; Cil T; Li X; Cicin I; Shen Y; Liu Z; Ozyilkan O; Igor B; Chen J; Oleksandr K; Chen Z; Zhang H; Fu Z; Dong Q; Song S; Yu JC; Zhang L
Cancer Med; 2023 Nov; 12(22):20847-20863. PubMed ID: 37935428
[TBL] [Abstract] [Full Text] [Related]
16. Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study.
Ruan X; Huang D; Zhan Y; Huang J; Huang J; Ng AT; Tsu JH; Na R
Elife; 2023 Nov; 12():. PubMed ID: 37917154
[TBL] [Abstract] [Full Text] [Related]
17. Prostaglandin 15d-PGJ
Slanovc J; Mikulčić M; Jahn N; Wizsy NGT; Sattler W; Malle E; Hrzenjak A
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166924. PubMed ID: 37898426
[TBL] [Abstract] [Full Text] [Related]
18. [Feasibility of a three-sided encapsulation procedure based on fascia anatomy in laparoscopic lateral lymph node dissection for middle and low rectal cancer].
Li WJ; Diao DC; Lin JX; Wang JH; Liao WL; Tang X; Xie JX; Ao L; Zhang XY; Yi XJ; Feng XC; Li HM; Lu XQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):968-976. PubMed ID: 37849268
[No Abstract] [Full Text] [Related]
19. Development of Novel Class of Phenylpyrazolo[3,4-
Aljohani AKB; El Zaloa WAZ; Alswah M; Seleem MA; Elsebaei MM; Bayoumi AH; El-Morsy AM; Almaghrabi M; Awaji AA; Hammad A; Alsulaimany M; Ahmed HEA
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834474
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in Prostate cancer Patients After Definitive treatment With PSA Level ≤0.2 ng/mL.
Lu Y; Wilson ZJ; Xu G; Xu Z; Pan T; Wei P
Clin Nucl Med; 2023 Dec; 48(12):1021-1027. PubMed ID: 37801580
[TBL] [Abstract] [Full Text] [Related]
[Next]
